As regenerative therapies evolve, aesthetic medicine is entering a transformative phase—thanks to platelet-derived exosomes. Supported by Mayo Clinic innovation, this next-generation skin therapy offers a natural, less invasive option for enhancing skin quality, speeding healing, and even supporting hair restoration.
Exosomes, or extracellular vesicles (EVs), are nanosized packages released by cells that carry proteins, lipids, and microRNAs essential for cellular communication. According to Dr. Deanna C. Menapace, facial plastic surgeon at the Mayo Clinic Cosmetic Center in Jacksonville, Florida, “Exosomes push on the gas for healing factors in the body,” helping stimulate collagen, improve elasticity, and reduce signs of aging.
While exosomes can be derived from stem cells, platelet-derived exosomes provide a more consistent, reproducible, and safe option. These exosomes are cell-free, meaning they don’t replicate—eliminating major concerns around immune response or oncogenesis. More importantly, their exact quantity can be measured, ensuring precision in application.
Mayo Clinic has developed a patented technology to process and store clinical-grade, sterile, and shelf-stable exosome products. Used topically in procedures like peels, microneedling, and laser resurfacing, results have included faster healing, enhanced skin tone and texture, and greater tolerance to active skincare ingredients.
Emerging studies highlight additional benefits:
- Reduced cellular aging: A 40% decrease in inflammatory secretions linked to old (senescent) skin cells after 12 weeks of use
- Photodamage repair: Noticeable collagen and elastin production after just six weeks
- Improved scar appearance: Faster wound healing and less inflammation
- Hair growth support: Extended hair growth phases and follicular stimulation
As Dr. Menapace notes, “Platelet-derived exosomes have emerged as a promising therapeutic frontier in aesthetic and regenerative medicine. There are so many potential applications.
